InMed Pharmaceuticals Inc. Common Shares

INM

...

INM: InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

Show INM Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of INM by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by INM's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on INM's company Twitter account

WallStreetBets

Number of mentions of INM in WallStreetBets Daily Discussion

INM News

Recent insights relating to INM

CNBC Recommendations

Recent picks made for INM stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in INM

Corporate Flights

Flights by private jets registered to INM